Study of HTLV-I Infection and Tropical Spastic Paraparesis

Evaluation of Patients With HAM/TSP

Recruiting Observational Study
HTLV-I Infection Tropical Spastic Paraparesis
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 120
Sex
Any
Study type
Observational
Participants needed
750 (estimated)
Sponsor
National Institute of Neurological Disorders and Stroke (NINDS) · NIH
Who this trial is looking for

This trial is looking for patients with HAM/TSP, a rare nerve condition related to HTLV-I infection. Participation involves regular evaluations and tests to study the progression of the condition.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have tested positive for HTLV infection.
  • I have a family member who is HTLV positive.
  • I am a healthy volunteer willing to participate.

You may not be able to join if

  • I am unwilling or unable to take part in the trial evaluations.
  • I have medical, social, or psychiatric issues that could affect my safety or compliance.
  • I am under the age of 18.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
Objective: Human T-lymphotropic virus type-I-associated myelopathy / tropical spastic paraparesis (HAM/TSP) is a rare neurologic disorder that affects less than 5% of patients infected with the HTLV-I virus. The purpose of this protocol is to study the natural history of HAM/TSP by monitoring clinical progression of patients longitudinally. Additionally, we will attempt to define the virological …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
* INCLUSION CRITERIA: Participants that meet one of the following criteria: * Test positive for HTLV infection (positive HTLV-1 ELISA followed by a positive Western blot) * Positive HTLV ELISA but a Western Blot that only partially fulfills the above criteria (seroindeterminate) * Have a family me…
Contacts

Christopher Y Itoh, M.D.

(301) 496-3825

christopher.itoh@nih.gov

CONTACT

Steven Jacobson, Ph.D.

(301) 496-3825

jacobsons@ninds.nih.gov

CONTACT